Literature DB >> 21472696

Digital multiplexed gene expression analysis using the NanoString nCounter system.

Meghana M Kulkarni1.   

Abstract

This unit presents the protocol for the NanoString nCounter Gene Expression Assay, a robust and highly reproducible method for detecting the expression of up to 800 genes in a single reaction with high sensitivity and linearity across a broad range of expression levels. The methodology serves to bridge the gap between genome-wide (microarrays) and targeted (real-time quantitative PCR) expression profiling. The nCounter assay is based on direct digital detection of mRNA molecules of interest using target-specific, color-coded probe pairs. It does not require the conversion of mRNA to cDNA by reverse transcription or the amplification of the resulting cDNA by PCR. Each target gene of interest is detected using a pair of reporter and capture probes carrying 35- to 50-base target-specific sequences. In addition, each reporter probe carries a unique color code at the 5' end that enables the molecular barcoding of the genes of interest, while the capture probes all carry a biotin label at the 3' end that provides a molecular handle for attachment of target genes to facilitate downstream digital detection. After solution-phase hybridization between target mRNA and reporter-capture probe pairs, excess probes are removed and the probe/target complexes are aligned and immobilized in the nCounter cartridge, which is then placed in a digital analyzer for image acquisition and data processing. Hundreds of thousands of color codes designating mRNA targets of interest are directly imaged on the surface of the cartridge. The expression level of a gene is measured by counting the number of times the color-coded barcode for that gene is detected, and the barcode counts are then tabulated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472696     DOI: 10.1002/0471142727.mb25b10s94

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  130 in total

Review 1.  Cancer/testis antigens and urological malignancies.

Authors:  Prakash Kulkarni; Takumi Shiraishi; Krithika Rajagopalan; Robert Kim; Steven M Mooney; Robert H Getzenberg
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

2.  Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?

Authors:  Yevgeniya J Ioffe; Katherine B Chiappinelli; David G Mutch; Israel Zighelboim; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2011-10-15       Impact factor: 5.482

Review 3.  Systems-level analysis of innate immunity.

Authors:  Daniel E Zak; Vincent C Tam; Alan Aderem
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

4.  The Olfactory Bulb Provides a Radioresistant Niche for Glioblastoma Cells.

Authors:  Cindy R Timme; Charlotte Degorre-Kerbaul; Joseph H McAbee; Barbara H Rath; Xiaolin Wu; Kevin Camphausen; Philip J Tofilon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-25       Impact factor: 7.038

5.  Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Rebecca L Kusko; John F Brothers; John Tedrow; Kusum Pandit; Luai Huleihel; Catalina Perdomo; Gang Liu; Brenda Juan-Guardela; Daniel Kass; Sherry Zhang; Marc Lenburg; Fernando Martinez; John Quackenbush; Frank Sciurba; Andrew Limper; Mark Geraci; Ivana Yang; David A Schwartz; Jennifer Beane; Avrum Spira; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

6.  Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.

Authors:  Thomas P Stricker; Andres Morales La Madrid; Alexandre Chlenski; Lisa Guerrero; Helen R Salwen; Yasmin Gosiengfiao; Elizabeth J Perlman; Wayne Furman; Armita Bahrami; Jason M Shohet; Peter E Zage; M John Hicks; Hiroyuki Shimada; Rie Suganuma; Julie R Park; Sara So; Wendy B London; Peter Pytel; Kirsteen H Maclean; Susan L Cohn
Journal:  Mol Oncol       Date:  2014-01-31       Impact factor: 6.603

7.  Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.

Authors:  Ariz Akhter; Noraidah Masir; Ghaleb Elyamany; Kean-Chang Phang; Etienne Mahe; Ali Matar Al-Zahrani; Meer-Taher Shabani-Rad; Douglas Allan Stewart; Adnan Mansoor
Journal:  J Neurooncol       Date:  2014-11-13       Impact factor: 4.130

8.  Beyond the H&E: Advanced Technologies for in situ Tissue Biomarker Imaging.

Authors:  Lauren E Himmel; Troy A Hackett; Jessica L Moore; Wilson R Adams; Giju Thomas; Tatiana Novitskaya; Richard M Caprioli; Andries Zijlstra; Anita Mahadevan-Jansen; Kelli L Boyd
Journal:  ILAR J       Date:  2018-12-01

9.  IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Authors:  Deborah L Hodge; Cyril Berthet; Vincenzo Coppola; Wolfgang Kastenmüller; Matthew D Buschman; Paul M Schaughency; Hidekazu Shirota; Anthony J Scarzello; Jeff J Subleski; Miriam R Anver; John R Ortaldo; Fanching Lin; Della A Reynolds; Michael E Sanford; Philipp Kaldis; Lino Tessarollo; Dennis M Klinman; Howard A Young
Journal:  J Autoimmun       Date:  2014-02-28       Impact factor: 7.094

10.  Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine.

Authors:  Umar Wazir; Kefah Mokbel
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.